Tag: treatments for neuroendocrine tumors
Dr. Daniel Lee to Be Featured Guest for CCF’s Luncheon with the Experts
Daniel Lee, MD, Section Chief of Nuclear Medicine at Ochsner Medical Center in Louisiana, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, February 3, 2022 from 12 noon to 1 pm, Eastern Time. Dr. Lee’s expertise…
READ MORE
October Luncheon with the Experts in White Plains, NY for the Neuroendocrine Tumor Community
The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, October 14, 2018 at 12:30 pm at the Westchester Hills Golf Club, 401 Ridgeway …
READ MORE
Breaking News: US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors
December 16, 2014: The US Food and Drug Administration (FDA) today approved “lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic…
READ MORE
Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting
Josh Mailman, President of the NorCal CarciNET Community and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…
READ MORE
2012 CNETS Canada Carcinoid and Neuroendocrine Conference Joins Medical Professionals, Patients & Caregivers
Carcinoid cancer and neuroendocrine tumor specialists from around the world, fascinating presentations on all aspects of these rare diseases, the opportunity to meet fellow carcinoid and neuroendocrine tumor (NETs) patients and caregivers from…
READ MORE
California Carcinoid and Neuroendocrine Tumor Conference Scheduled for January
Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California. The latest developments in NET cancers, including clinical trials, …
READ MORE
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MORE
